Tirzepatide, a dual GIP/GLP-1 receptor agonist, may also offer more favorable muscle preservation profiles, although further studies are needed
Retatrutide in powder form sometimes referred to as lyophilised (freeze-dried) peptide is not a licensed pharmaceutical product available through UK pharmacies or NHS prescribing
For anti-diabetic GLP-1s, Medicares policy and Commercial payers reluctance to offer widespread coverage of AOMs leads to a bolus of comorbid patients in both channels attempting to initiate anti-diabetic GLP-1 therapy for their weight-loss advantages
Beyond glucose regulation, GLP-1 receptor agonists slow gastric emptying, which helps people feel fuller for longer periods and reduces appetite through effects on brain centers that control hunger
This helps increase metabolism, enhance energy, and create longer-lasting fullness after meals